bimatoprost · Thea Pharma · NDA 217307
Zolymbus
Earliest generic entry, as listed
8 Jun 2036
Blocked by patent: US 10314780.
Listed patents · 1 unexpired
| Patent | Claims | Expires |
|---|---|---|
| US 10314780 | drug product, use U-1295 · sets the listed date | 8 Jun 2036 |
Exclusivities · 1 unexpired
| NDF | new dosage form | 9 Sep 2028 |
Paragraph IV certifications · 0
No Paragraph IV certification listed by FDA for this drug.
The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.
Event history
No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.
Products covered · 1
| NDA · product | Form | Strength | Listed expiry |
|---|---|---|---|
| 217307 · 001 · RLD | gel, ophthalmic | 0.01% | 8 Jun 2036 |